Yamashita Health CARE Holdings Rejects Shareholder Proposals for Board Changes and Dividend Increases

TOKYO, Jul 22 (Pulse News Wire) – Yamashita Health Care Holdings,inc. (9265.T) rejected shareholder proposals submitted by Triple Four Investment Fund for changes to the board composition and dividend policies during its upcoming annual general meeting scheduled for July 22.

The company opposed the nomination of two external directors, Norio Takeuchi and Daichi Koga, citing concerns over their independence due to existing ties with Sakura Cross Group and overlapping skill sets within the current board structure. Additionally, the proposal to increase dividends to ¥100 per share was also rejected, as the company believes such a move could constrain future growth investments and compromise long-term value creation.

Furthermore, Yamashita Health Care declined to establish an independent committee focused solely on enhancing enterprise value, arguing that the current governance framework allows for flexible and effective decision-making aligned with shareholders' interests. The company maintains its commitment to balanced investment strategies aimed at sustainable growth and improved capital efficiency while ensuring robust shareholder returns through strategic initiatives outlined in its medium-term plan.